I Changed My Mind About SARMs
Timeline
Video Summary
The speaker discusses selective androgen receptor modulators and why people call them safer than steroids. He explains that early marketing framed SARMs as targeted compounds with fewer side effects. Over time, he says user experiences made him reconsider how predictable these drugs really are. He describes that people often assume SARMs are mild, yet they still influence endocrine signaling. He warns that dose creep happens quickly when expectations are set by exaggerated online claims. He emphasizes that many products are underdosed, overdosed, or contaminated, creating hidden risk. His main point is that labeling something a SARM does not automatically make it safer.
He compares SARMs to anabolic steroids by focusing on suppression and downstream hormone disruption. He notes that some users experience side effects that mirror traditional androgens, including hair loss concerns. He also mentions gynecomastia risk when hormones shift in unpredictable directions. He frames blood work as essential, because lipids like HDL and LDL can change in unwanted ways. He suggests that liver stress can appear, especially when products are oral and poorly manufactured. He cautions that risk is amplified when users stack compounds or extend cycles without supervision. He argues that the gap between the promise and reality is what changed his opinion most.
He recommends approaching any performance drug with the same seriousness used for testosterone or steroids. He encourages people to prioritize long term health over short term physique outcomes and social validation. He suggests planning monitoring before starting, including blood pressure checks and routine laboratory follow up. He highlights that cardiovascular events like heart attacks are possible when risk factors pile up over time. He emphasizes choosing conservative decisions, because many outcomes only appear after months or years. He encourages learning fundamentals, asking better questions, and avoiding impulsive experimentation. He closes by saying his change of mind comes from pattern recognition, not from fear mongering.
Drug Callouts
Condition Callouts
Key Takeaways
- He no longer views SARMs as reliably safer than traditional anabolic steroids.
- Marketing, mislabeling, and contamination can make real world outcomes unpredictable.
- Suppression and endocrine disruption are emphasized as meaningful risks with SARMs use.
- Lab monitoring is encouraged because lipids and blood pressure can worsen quietly.
- He urges conservative decisions and long term health priorities over quick physique gains.